About this trial
This study examines the respiratory outcomes of preterm infants born at gestational ages less than 29 weeks, spanning from birth to 24 months corrected age. It delves into the intricacies of respiratory function impairment attributable to diverse factors, such as respiratory distress syndrome, bronchopulmonary dysplasia, postnatal corticosteroids, ventilatory support, as well as nutritional aspect during NICU stay. Furthermore, it scrutinizes the incidence of chronic respiratory diseases stemming from these conditions, assessing their long-term impact on respiratory prognosis post-discharge. In addition to respiratory aspects, the research extends its focus to the growth and developmental outcomes of preterm infants. By synthesizing these multifaceted elements, the study aspires to enhance current treatments and preventative measures for respiratory conditions in preterm infants.
Eligibility criteria
Qualifiers
Infants born at gestational age less than 29 weeks with cohort consent obtained within 7 days of birth
Disqualifiers
death within 3 days of birth
severe structural heart defects
structural abnormalities in the upper airway, lungs, or chest
congenital anomalies that may impact cardiopulmonary function
Trial design
Treatments tested in this trial
- Standard care for preterm infants
Treatment groups
Sponsors and collaborators
Seoul National University Hospital
Lead sponsor
Asan Medical Center
Collaborator
Samsung Medical Center
Collaborator
Seoul National University Bundang Hospital
Collaborator
Chonnam National University Hospital
Collaborator
Severance Hospital, Yonsei University College of Medicine
Collaborator
Ajou University Medical Center
Collaborator